1-15 of 92
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CEIBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
MinuteCE®Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Florence Odufalu, MD
David T. Rubin, MD
The Evolving Role of Small Molecules in IBD Care
MinuteCE®The Evolving Role of Small Molecules in IBD Care
Florence Odufalu, MD
David T. Rubin, MD
Putting It All Together: A Practical IBD Treatment Selection Primer
MinuteCE®Putting It All Together: A Practical IBD Treatment Selection Primer
Ugo Iroku, MD, MHS
Michael Dolinger, MD, MBA
David T. Rubin, MD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
MinuteCE®Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Michael Dolinger, MD, MBA
Florence Odufalu, MD
- advertisement
The Future of Biologic Treatment in IBD: What’s on the Horizon
MinuteCE®The Future of Biologic Treatment in IBD: What’s on the Horizon
Michael Dolinger, MD, MBA
David T. Rubin, MD
Translating Advances into Practice: Lessons from Today’s IBD Landscape
MinuteCE®Translating Advances into Practice: Lessons from Today’s IBD Landscape
Ugo Iroku, MD, MHS
David T. Rubin, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Navigating IBD Guidelines: What Clinicians Need to Know Now
MinuteCE®Navigating IBD Guidelines: What Clinicians Need to Know Now
Michael Dolinger, MD, MBA
David T. Rubin, MD
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
MinuteCE®Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Survey Says: Aligning Early Advanced IBD Therapy with Patient Priorities
CME/CESurvey Says: Aligning Early Advanced IBD Therapy with Patient Priorities
Jessica Allegretti, MD, MPH, FACG, AGAF
Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF
Russell D. Cohen, MD, FACG, AGAF
- advertisement
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
CME/CEIBD in Focus: A Case-Based Approach to Diagnosis and Assessment
David T. Rubin, MD
Michael Dolinger, MD, MBA
Targeting Inflammation in IBD: Localized vs Systemic Strategies
MinuteCE®Targeting Inflammation in IBD: Localized vs Systemic Strategies
David T. Rubin, MD
Michael Dolinger, MD, MBA
Understanding the Microbiome’s Role in IBD Management
MinuteCE®Understanding the Microbiome’s Role in IBD Management
Florence Odufalu, MD
